HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
4-Methoxycarbonylphenylboronic acid → Methyl 3-(3-methyl-5-{[6-(1-methyl-1H-pyrazol-4-yl)-4-oxospiro[chroman-2,4'-piperidin]-1'yl]carbonyl}-1H-indazol-1-yl)benzoate
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|---|---|---|
| Edukt | 4-Methoxycarbonylphenylboronic acid | HCID 2734369 | — |
| Edukt | 3-(Methoxycarbonyl)benzeneboronic acid | HCID 2734714 | — |
| Edukt | 1'-[(3-methyl-1H-indazol-5-yl)carbonyl]-6-(1-methyl-1H-pyrazol-4-yl)spiro[chroman-2,4'-piperidin]-4-one | HCID 178434288 | — |
| Produkt | Methyl 3-(3-methyl-5-{[6-(1-methyl-1H-pyrazol-4-yl)-4-oxospiro[chroman-2,4'-piperidin]-1'yl]carbonyl}-1H-indazol-1-yl)benzoate | HCID 58208705 | — |
Reaktionsschritte
The intended compound was produced according to the procedure described in Example 28-2 but using 1′-[(3-methyl-1H-indazol-5-yl)carbonyl]-6-(1-methyl-1H-pyrazol-4-yl)spiro[chroman-2,4′-piperidin]-4-one and [3-(methoxycarbonyl)phenyl]boronic acid in place of 1′-[(3-methyl-1H-indazol-6-yl)carbonyl]-6-(1-methyl-1H-pyrazol-4-yl)spiro[chroman-2,4′-piperidin]-4-one and [4-(methoxycarbonyl)phenyl]boronic acid.
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patentnummer | US08524730B2 |
| Quelldatensatz | uspto-grants-2013_09 |
| ORD ID | ord-87e6f9a9af334c1caa8640553460e833 |
| Quellennotiz | uspto-grants-2013_09 |